BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, April 26, 2026
Home » Topics » Financings

Financings
Financings RSS Feed RSS

Cancer treatment developer Apollomics gets listed on Nasdaq in SPAC merger

April 3, 2023
By Zhang Mengying
Cancer treatment developer Apollomics Inc. merged with special purpose acquisition company (SPAC) Maxpro Capital Acquisition Corp., gaining a listing on Nasdaq under the ticker APLM and raising $23.65 million of private investment in public equity (PIPE).
Read More
Franz Pfister and Julia Moosbauer

Deepc €12M fundraise will expand functionality of radiology AI platform

March 31, 2023
By Shani Alexander
As artificial intelligence becomes more central to clinical radiology workflows, Deepc GmbH will use the €12 million (US$13 million) it recently raised in its series A round to develop additional features within its Deepcos radiology artificial intelligence (AI) platform to allow for faster and more accurate diagnoses.
Read More

Financings for March 31, 2023

March 31, 2023
Med-tech firms raising money in public or private financings, including: Bioventus, G Medical Innovations, Wellth.
Read More

Financings for March 31, 2023

March 31, 2023
Biopharmas raising money in public or private financings, including: Alligator, Aptevo, Checkpoint, Medexus, Renovorx, TC, Xoma, Zealand.
Read More

Shoulder Innovation receives broad shouldered investor support for integrated Inset system

March 30, 2023
By David Godkin
Shoulder Innovations Inc. (SI) reported closing of an oversubscribed $42 million series D financing to further advance commercialization and distribution of its integrated Inset system. In addition to functions performed by SI’s humeral short stem, reverse and stemless components the new implant has proven its ability to overcome loosening of the glenoid, one the most challenging procedures to perform during arthroplasty.
Read More

Financings for March 30, 2023

March 30, 2023
Med-tech firms raising money in public or private financings, including: Delcath Systems, Watershed Informatics.
Read More

Financings for March 30, 2023

March 30, 2023
Biopharmas raising money in public or private financings, including: Akari, Avadel, Biomea Fusion, Redhill, Salubris, Smart Immune, Sorrento, Trobix and Viking.
Read More
Wireframe hands, coins

Genialis lands $13M to expand AI clinical biomarker platform

March 29, 2023
By Meg Bryant
Genialis Inc. reeled in $13 million in a series A financing co-led by Taiwania Capital and Debiopharm Innovation Fund. The funds will be used to build out the company’s store of clinically validated biomarker models for individualized cancer diagnosis.
Read More

Financings for March 29, 2023

March 29, 2023
Med-tech firms raising money in public or private financings, including: Bivacor.
Read More

Financings for March 29, 2023

March 29, 2023
Biopharmas raising money in public or private financings, including: Biomea, Modus, Polypid, Vakona, Zyus.
Read More
Previous 1 2 … 289 290 291 292 293 294 295 296 297 … 667 668 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 24, 2026.
  • Illustration of a tumor

    Detecting the invisible: minimal residual disease at AACR 2026

    BioWorld Science
    Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
  • Boy cupping ear with soundwave graphic

    A free gene therapy? Regeneron’s Otarmeni approved for hearing loss

    BioWorld
    Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
  • Illustration of human face that looks abstract and digital

    AACR 2026: The age of agentic AI in oncology

    BioWorld Science
    New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
  • In the clinic for April 21, 2026

    BioWorld
    Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing